Company Legal Name
Latest Valuation
Founded Year
Headquarter
OpenEvidence Inc. develops AI-powered clinical decision support software that serves as an intelligent copilot for healthcare professionals at the point of care. Founded in 2021 and headquartered in Cambridge, Massachusetts, the company leverages artificial intelligence to assist doctors in making critical medical decisions by providing real-time, evidence-based recommendations. The platform addresses the growing need for enhanced clinical decision-making tools in an increasingly complex healthcare environment. With a current valuation of $3.5 billion, OpenEvidence has established itself as a significant player in the healthcare AI sector. The company continues to focus on expanding its clinical applications and improving diagnostic accuracy for medical professionals.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





